Nature Chemical Biology Submission Guide: What to Prepare Before You Submit

This journal is not the Nature-branded version of a chemistry journal or a biology journal. It occupies a very specific niche: work where chemistry and biology are genuinely interdependent, not just adjacent.

The editorial team screens for three things before anything else:

The most common submission mistake is work where the chemistry is interesting but the biology is confirmatory. A new probe that works better than existing probes is not enough unless it reveals biology that was previously invisible. The chemical advance must unlock a biological question.

Cell assays added to demonstrate "relevance" are not the same as biological discovery driven by chemical logic. If the biological experiments serve only to validate a chemical advance, the paper belongs in a chemistry journal rather than in Nature Chemical Biology.

Nature Chemical Biology readers include chemists who think biologically and biologists who think chemically. The introduction, methods, and discussion must be accessible to both. Technical jargon from either field needs enough context that a reader from the other field can follow the reasoning.

Nature Chemical Biology accepts presubmission enquiries when the scope case is uncertain. Submit the enquiry through the journal's online manuscript tracking system, providing an abstract of your work; it is not a way to submit a full manuscript.

The journal asks for an abstract of your work in a presubmission enquiry. A strong enquiry also makes these points visible:

• a brief description of the work, in the form of an abstract

• the main finding and why it matters at the chemistry-biology interface

• why the work fits this specific journal rather than a pure chemistry or biology venue

• the key data that illustrate the discovery

The enquiry should make the chemistry-biology integration visible quickly. It saves preparation time if the work is actually better suited to Nature Chemistry, ACS Chemical Biology, Cell Chemical Biology, Nature Methods, JACS, or a biology-specific venue.

Submit a single file containing the manuscript text with display items (figures, schemes, and tables) integrated. Nature Chemical Biology uses a standard Nature-format manuscript:

• title (concise, informative, accessible to both disciplines)

• abstract (150 words or less, explaining both the chemical and biological dimensions)

• introduction that brings both audiences along

• results that integrate chemical and biological findings

• discussion that contextualizes the discovery for both fields

• methods with sufficient detail for both chemical and biological reproduction

The cover letter is important at Nature Chemical Biology because it is where you explain the interdisciplinary significance. The letter should:

• state the main finding in one or two sentences that a chemist and a biologist would both understand

• explain what biological question the chemistry addressed and why other approaches could not answer it

• identify the broader audience beyond your immediate subfield

• explain why Nature Chemical Biology is the right venue rather than a discipline-specific journal

Supplementary information goes as a separate file. Include:

• detailed synthetic procedures and compound characterization

• full biological methods, controls, and statistical analyses

• additional figures and data that support the main manuscript

• any computational methods or analyses

Both the chemistry and biology supplementary data should be thorough enough to satisfy reviewers from each discipline.

The most common failure is a manuscript that assumes the reader has either chemistry or biology expertise but not both. If the introduction spends three paragraphs on the biological context and one sentence on the chemical approach (or vice versa), the framing is unbalanced. Both fields need enough context that a reader from the other discipline can follow.

Nature Chemical Biology expects mechanistic depth. A paper that shows a chemical compound has a biological effect but cannot explain the mechanism at a molecular level is premature for this journal. Even preliminary mechanistic insights strengthen the submission significantly. Purely phenomenological observations without mechanistic follow-up will struggle in review.

If the chemical characterization of your probes, compounds, or materials is weaker than what ACS journals or Angewandte Chemie would accept, Nature Chemical Biology reviewers will notice. The chemistry side of the paper must meet full chemistry-journal standards for characterization, purity, and reproducibility. For small molecules, that means complete NMR (1H and 13C at minimum), high-resolution mass spectrometry, and purity data. For biologics or polymeric materials, the appropriate characterization suite for that compound class must be complete.

Similarly, the biological experiments need to meet the rigor standards of Nature-family biology journals. Appropriate controls, statistical treatment, multiple orthogonal approaches, and honest discussion of limitations are all expected. Cutting corners on the biological rigor is one of the most common reasons for reviewer criticism.

Specifically, editors expect: negative controls alongside every positive result, dose-response data rather than single-dose effects, orthogonal validation of key findings (if you show a chemical effect, confirm it with a genetic or independent chemical approach), and statistical treatment that matches the experimental design. If you are uncertain about what constitutes appropriate biological controls for your system, consult a biologist colleague before submission.

NCB's flow follows the Nature Portfolio editorial process. The journal's metrics page (checked 2026-10-09) reports a median of 11 days from submission to first editorial decision, meaning the point where a manuscript is sent for peer review or rejected, and a median of 258 days from submission to acceptance. It publishes no durations for the other stages, so the stages below carry no day counts.

• Upload. The Nature Portfolio manuscript tracking system accepts the package, and the journal's editorial assistant checks that the manuscript and associated materials are complete.

• First editor read. The manuscript is assigned to an editor, who consults the editorial team and decides whether to send it for peer review. The editor evaluates chemistry-biology integration, mechanistic depth, and interdisciplinary framing; the journal's median to this decision is 11 days.

• Reviewer invitations. If the paper goes to review, the editor contacts researchers with relevant expertise. Nature Portfolio policy says formal review is typically to two or three reviewers, and a chemistry-biology paper often needs reviewers spanning both fields.

• Peer review. Reviewers read the manuscript and submit reports. Chemistry-heavy papers can take longer because reviewers verify synthetic procedures and characterization.

• Editorial decision. The editors discuss the reports and either invite a revised version or decline. If you are invited to revise, resubmit through the link in the decision email, not as a new manuscript.

• Revision rounds and acceptance. The journal's median from submission to acceptance is 258 days, which includes peer review and time in revision.

Across chemistry-biology manuscripts targeting Nature Chemical Biology, three recurring decision risks matter most across submissions that the journal's editors filter out at the desk-screen stage.

Relevant published-guidance constraints:

• Nature Chemical Biology published submission policies, the journal accepts optional presubmission enquiries when fit is uncertain, accepts manuscripts via Nature Portfolio journal page with Article cap 4,500 words main text + 150-word abstract + 6 display items

• its aims and scope say the review process emphasizes rigorous chemical and biological characterization

• the core discovery must require both chemistry and biology to explain

• the chemistry must enable a biological insight that would not have been accessible otherwise

• the mechanistic understanding must go beyond phenomenological observation

Use the three checks below before you open Nature Portfolio journal page upload slot.

Integration failure: chemistry and biology are additive rather than mutually necessary

Across Nature Chemical Biology-targeted manuscripts, we consistently see authors submit work where the chemistry is technically impressive (new probe, new inhibitor, new chemical-biology tool, new bioorthogonal handle, new activity-based probe, new photoaffinity reagent, new chemical proteomics platform, new CRISPR-Cas-engineering chemistry, new prodrug, new PROTAC, new molecular glue)

The biological experiments are competently executed, but the relationship between chemistry and biology is additive rather than integrative: the chemical approach confirms what biological methods (genetics, biochemistry, imaging, omics) already suggested, demonstrates that a known biological mechanism can be observed with a new tool, validates a target the field already knew, or characterizes a phenotype prior biology had described.

Nature Chemical Biology editors apply a chemistry-unlocks-biology test at desk: the chemical approach must be necessary for the biological discovery (not just one of several possible approaches), the biology revealed must not have been accessible by standard genetic / biochemical / imaging / omics methods alone, and the integration must produce an insight neither discipline alone could reach.

Specific patterns editors flag: probe-validation papers where the probe confirms a known target without revealing new target biology; chemical-tool-application papers where the tool reveals what genetic-tool experiments had previously shown; new-inhibitor papers where the inhibitor confirms known target biology without revealing new mechanism / pathway / interaction; new-CRISPR-chemistry papers where the chemistry enables previously-CRISPR-accessible biology with marginal improvement; chemoproteomics papers where the new method identifies targets previously known from genetic screens.

Manuscripts with additive framing can be redirected before external review to chemistry-specific venues (Journal of the American Chemical Society, Angewandte Chemie International Edition, Chemical Science, Chemistry: A European Journal, Organic Letters, Bioconjugate Chemistry, ACS Chemical Biology); biology-specific venues (Nature Communications, eLife, PNAS, Cell Reports, Molecular Cell, Cell Chemical Biology) where additive chemistry-biology integration is acceptable; or methods-focused venues (Nature Methods, Nature Protocols).

The fix is to identify what specifically the chemistry unlocks that biology could not have accessed without the chemical approach, restructure the manuscript so the new biology is the contribution and the chemistry is the means, demonstrate that genetic / biochemical alternatives would not have revealed the same biology, and write the abstract and cover letter to make the chemistry-enables-new-biology relationship explicit.

Check whether your Nature Chemical Biology manuscript proves chemistry and biology are mutually necessary →

Biology-rigor failure: controls, replication, statistics, or model systems fall below Nature-family standards

We frequently see Nature Chemical Biology manuscripts present strong chemistry with biological experiments that would not meet the rigor expected at Nature / Cell / Science / Nature Communications biology-journal standards.

Nature Chemical Biology editors specifically check biology rigor against the same bar a pure biology journal would apply:

• missing negative controls (vehicle controls, scrambled-probe controls, dead-enzyme controls, target-negative cells)

• single-dose effects without dose-response (EC50 / IC50 / Kd / Km with full curves rather than single-point activity)

• key biological claims validated by only one approach (without orthogonal genetic knockdown, chemical inhibition, and complementation triangulation)

• statistical treatment insufficient for the biological conclusions (no biological replicates n >= 3 separate from technical replicates, no appropriate test by data type, no multiple-comparisons correction, no effect-size reporting)

• insufficient model-system breadth (single cell line, single mouse strain, single fly genotype, single bacterial strain when the claim implies generality)

• missing in vivo validation when in vitro work is followed by mechanistic claims requiring tissue context

• missing patient-derived validation where translational implications are claimed

Nature Chemical Biology editors assess both chemistry rigor and biology rigor independently before sending to review, and submissions weaker on the biology side than what a comparable Nature-family biology journal would accept face desk rejection regardless of chemistry strength.

The fix is to apply Nature-biology standards to the biological experiments before submission: include all relevant negative and positive controls, complete dose-response with curves, validate key claims with at least 2 orthogonal approaches (genetic + chemical + biochemical), apply biological replicates n >= 3 with appropriate statistics, demonstrate breadth across at least 2 model systems where the claim implies generality, and include in vivo or patient-derived validation where translational claims are made.

Check whether your Nature Chemical Biology biology controls meet Nature-family rigor →

Chemistry-characterization failure: NMR, HRMS, purity, stereochemistry, or structural confirmation is incomplete

The third recurring pattern in Nature Chemical Biology-targeted manuscripts is biologically compelling work with chemical characterization that does not meet the standards an ACS or Wiley chemistry journal would require for new compounds.

Nature Chemical Biology reviewers include chemists who apply full chemistry-journal rigor to the chemical side of every manuscript, and submissions where the chemical characterization would be acceptable at a biology journal but not at a chemistry journal face desk rejection or major revision.

The specific characterization elements Nature Chemical Biology chemistry reviewers check for:

• complete 1H NMR + 13C NMR with full assignment for new organic compounds

• appropriate 2D NMR (COSY, HSQC, HMBC, NOESY) for stereochemistry assignment

• high-resolution mass spectrometry (HRMS) with calculated vs found mass to 4 decimal places

• IR spectroscopy with key band assignments

• melting point with literature comparison for known scaffolds

• elemental analysis (the journal encourages it within ±0.4% for small molecules) or chromatographic purity with method documentation

• X-ray crystallography with CIF deposition (CCDC) for novel structures or critical stereochemistry

• circular dichroism for chiral compounds

• UV-Vis with extinction coefficients for chromophores

• absorption / emission spectra with quantum yields for fluorescent probes

• click-chemistry handle characterization for bioorthogonal probes

• activity-based-probe labeling validation with target-protein-positive vs target-protein-negative controls

Manuscripts where any of these elements is missing for new compounds face revision requests demanding the missing data.

The fix is to apply chemistry-journal characterization standards to every new compound before submission, deposit crystal structures with CCDC, provide full spectra in supplementary, document purity with HPLC trace + method, and include all standard characterization that a JACS / Angewandte / Chemical Science submission would require.

Check whether your Nature Chemical Biology manuscript is submission-ready →

Submission caps: Nature Chemical Biology Articles cap at 4,500 words of main text (excluding abstract, Methods, references, and figure legends) with a 150-word abstract and up to 6 display items (figures or tables). The journal does not publish a Methods word limit and asks that Methods be written as concisely as possible. Initial submissions can be PDF, Word or TeX/LaTeX (compiled PDFs) and need no special formatting. After acceptance in principle, final submissions must be Word or TeX/LaTeX, because PDFs are not accepted, and a single ChemDraw (.cdx) file of the paper's numbered structures is requested with the final revised version for deposition to PubChem. Submit through the Nature Portfolio journal page portal.

SciRev author-reported review times and Clarivate 2026 JCR release bibliometric data provide additional benchmarks when planning your submission timeline.

Before submitting to Nature Chemical Biology, a Nature Chemical Biology submission readiness check identifies whether your interdisciplinary integration, biological rigor, and mechanistic depth meet the editorial bar before you commit to the submission.

Or see example reports before you finalize.

No amount of compliance rescues a paper the editor considers out of scope. See whether Nature Chemical Biology before I reformat is the right target for my abstract.

• Annual Review of Biochemistry submission guide

• Nature Chemical Biology submission guidelines

• Nature Chemical Biology preparing your submission

• Nature Chemical Biology presubmission enquiries

• Nature Chemical Biology editorial process

• Nature Chemical Biology editorial policies

Last verified: 2026-10-09 against Nature Chemical Biology submission, presubmission-enquiry, and editorial-process pages.